DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma

NCT03115333 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

146

Enrollment

NETWORK

Sponsor class

Conditions

Gliosarcoma
Recurrent Glioblastoma

Interventions

DIAGNOSTIC_TEST: Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging

Sponsor

ECOG-ACRIN Cancer Research Group

Collaborators

[object Object]